Pamela L. Scheinman

1.6k citations
54 papers · 1.1k indexed · h-index 18

Pamela L. Scheinman

52 papers receiving 1.0k citations

Peers

Pamela L. Scheinman
Comparison fields: 5 of 106
  • Dermatology 752
  • Immunology and Allergy 303
  • Periodontics 70
  • Rheumatology 89
  • Immunology 117
Replace Th. van Joost with:
Th. van Joost Netherlands
Julien Lambert Belgium
J. Sánchez‐Pérez Spain
Dominique Tennstedt Belgium
R. Valsecchi Italy
T. Cainelli Italy
Virginia Fernández‐Redondo Spain
Necmettın Akdeniz Türkiye
B. N. Statham United Kingdom
Cathryn Sibbald Canada
Pamela L. Scheinman relative to Th. van Joost Netherlands Th. van Joost's profile →
Citations per field
00.5×10×20×26×
Th. van Joost · 1×
Citations per year

Countries citing papers authored by Pamela L. Scheinman

Since Specialization
Citations

This map shows the geographic impact of Pamela L. Scheinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela L. Scheinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela L. Scheinman more than expected).

Fields of papers citing papers by Pamela L. Scheinman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela L. Scheinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela L. Scheinman. The network helps show where Pamela L. Scheinman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pamela L. Scheinman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pamela L. Scheinman Line = papers co-authored together Pamela L. Scheinman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20201
2 20192
3 20184
4 201732
5 201751
6 201651
7 201660
8 20107
9 20106
10 200821
11 200810
12 200811
13 200821
14 200212
15 200111
16 19979
17 19963
18 19954
19 19947
20 199066

About Pamela L. Scheinman

Pamela L. Scheinman is a scholar working on Dermatology, Chemical Health and Safety and Immunology and Allergy, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Contact Dermatitis and Allergies (36 papers), Allergic Rhinitis and Sensitization (12 papers), Dermatology and Skin Diseases (8 papers), Occupational exposure and asthma (7 papers), Nail Diseases and Treatments (5 papers), Autoimmune Bullous Skin Diseases (5 papers), Pesticide Exposure and Toxicity (4 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Dermatology (752 citations), Immunology and Allergy (303 citations) and Periodontics (70 citations). Pamela L. Scheinman has collaborated with scholars based in United States, Thailand and Australia. Frequent co-authors include Alice B. Gottlieb, Adam Asarch, Ari M. Goldminz, Bruce A. Brod, Susan Nedorost, Christen M. Mowad, Michelle Bush, Nicole Dumont, Jin Lee and Shiu-chung Au. Their work appears in journals such as PLoS ONE, Nature Reviews Disease Primers and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026